SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-18-023680
Filing Date
2018-05-15
Accepted
2018-05-15 11:59:25
Documents
1
Group Members
FIFE TRADING, INC.ILIAD MANAGEMENT, LLCJOHN M FIFE

Document Format Files

Seq Description Document Type Size
1 NONE doc1.htm SC 13G 114490
  Complete submission text file 0001140361-18-023680.txt   116216
Mailing Address 303 EAST WACKER DRIVE SUITE 1040 CHICAGO IL 60601
Business Address 303 EAST WACKER DRIVE SUITE 1040 CHICAGO IL 60601 312-565-1569
Iliad Research & Trading, L.P. (Filed by) CIK: 0001462830 (see all company filings)

IRS No.: 113688679 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Subject) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88438 | Film No.: 18834489
SIC: 2834 Pharmaceutical Preparations